We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Sudden Cardiac Arrest Risk Is Unpredictable

By HospiMedica International staff writers
Posted on 02 Mar 2015
Print article
Patients with congenital cardiac muscle weakness must be treated as carefully as patients with ischemic heart failure that suffered a heart attack, according to a new study.

Researchers at MedUni Vienna (Austria) studied 60 patients (median age 57 years) with dilated cardiomyopathy and a left ventricular ejection fraction (LVEF) lower than 0.5, and 30 control subjects with a LVEF of over 0.5. The study protocol included initial assessment, a second assessment after three years, and a final follow-up that included baroreceptor reflex sensitivity, short-term spectral analysis of heart rate variability, a signal-averaged electrocardiogram (ECG), and other indicators. The end points were cardiac death, resuscitated cardiac arrest, and arrhythmic death.

The results showed that cardiac death occurred in 21 patients. Resuscitated cardiac arrest and arrhythmic death caused by ventricular tachyarrhythmia (VT) was observed in 7 and 10 patients, respectively. The researchers concluded that noninvasive testing and LVEF could not reliably identify patients with dilated cardiomyopathy at risk of fatal VT, and recommended that an implantable defibrillator (ICD) be considered even in patients with mild cardiac muscle weakness. The study was published in the December 2014 issue of Circulation: Arrhythmia and Electrophysiology.

“We investigated cardiac muscle weakness patients with non-dangerous cardiac rhythm disturbances; the number of potentially fatal cases is much higher than anticipated. This difference is reflected in the risk assessment of sudden cardiac death,” said lead author Thomas Pezawas, MD, of the department of clinical cardiology. “Patients with non-ischemic heart cardiac muscle weakness are assessed with a lower risk of sudden cardiac death and therefore are less likely to receive a primary prevention ICD.”

Prophylactic ICD implantation is currently recommended in dilated, non-ischemic heart disease and LVEF of 0.30–0.35 or less. LVEF is an indicator of the heart's function which measures the volume of the beat in relation to the overall volume of blood in the left ventricle.

Related Links:

MedUni Vienna


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Breast Imaging Workstation
SecurView

Print article

Channels

Surgical Techniques

view channel
Image: NTT and Olympus have begun the world\'s first joint demonstration experiment of a cloud endoscopy system (Photo courtesy of Olympus)

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Endoscopes, which are flexible tubes inserted into the body's natural openings for internal examination and biopsy collection, are becoming increasingly vital in medical diagnostics. Their minimal invasiveness... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.